Russell Investments Group
ALDR

Russell Investments Group’s Alder Biopharmaceuticals ALDR Stock Holding History

Russell Investments Group’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-300
Closed -$4K – 3034
2019
Q1 		$4K Buy
+300
New +$3.89K ﹤0.01% 2900
2018
Q4 		– Sell
-2,200
Closed -$37K – 3098
2018
Q3 		$37K Sell
2,200
-200
-8% -$3.62K ﹤0.01% 2863
2018
Q2 		$38K Buy
+2,400
New +$36.5K ﹤0.01% 2840
2018
Q1 		– Sell
-2,500
Closed -$29K – 3067
2017
Q4 		$29K Buy
+2,500
New +$27.9K ﹤0.01% 2912
2017
Q3 		– Sell
-42,416
Closed -$486K – 3052
2017
Q2 		$486K Buy
42,416
+2,837
+7% +$52.5K ﹤0.01% 2423
2017
Q1 		$823K Buy
39,579
+23,437
+145% +$519K ﹤0.01% 2206
2016
Q4 		$334K Buy
+16,142
New +$420K ﹤0.01% 2588

Other funds holding ALDR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return